Kojin Therapeutics

Kojin Therapeutics

Kojin Therapeutics is developing transformative medicines based on a groundbreaking approach to ferroptosis and cell state biology.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Internal medicine

Location

0

Cambridge, Massachusetts

CEO

Founder

Stephanie Dougan

Benjamin Cravatt

Stuart Schreiber

Vasanthi Viswanathan

Pitchbook URL

pitchbook.com/profiles...462867-31

Email Address

hello@kojintx.com

Full Address

451 D Street, Suite 502 Boston, MA 02210, USA0

Investors

Eventide Asset Management

Polaris Partners

Alexandria Venture Investments

Total Funding Amount (USD)

60,000,000

Latest Funding Round Date

June 9, 2021

Board of Directors

Nagesh Mahanthappa

Stuart Schreiber

Latest Funding Type

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

60,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Kojin Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.